Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028509 · ClinicalTrials.gov registry record
Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 66
- Enrollment target
NCT00028509: Completed study, sponsored by Children's Oncology Group.
NCT00028509 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028509 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects. PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.
Interventions
- PROCEDURE management of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2002-07 |
What the finished NCT00028509 record still lists
NCT00028509 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which management of therapy complications is the first listed.
NCT00028509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00028509 about?
NCT00028509 is a clinical study titled "Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201". RATIONALE: Assessing the effects of methotrexate on brain function in children may improve the ability to plan treatment and decrease side effects. PURPOSE: Clinical trial to compare brain function of children who have been previously treated with methotrexate.
What is the current status of trial NCT00028509?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2002-07.
What interventions are being tested in trial NCT00028509?
The interventions under investigation include: management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00028509?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia